Description
Immunogenicity is a significant area of discussion in the pharmaceutical and biotech industry with new strategies and practices being developed, also it is a primary safety concern for regulators.
Key Benefits:
Examine the efficient methods of immunogenicity testing
Assess immunogenicity risk assessment strategies
Evaluate the impact of immunogenic responses on efficacy and safety
Analyse the strategies for pre-clinical immunogenicity testing
Discover how to address immunogenicity issues related to formulation
Gain an insight into the impact of anti-drug IgE antibody testing
Hear case study updates from top biopharmaceuticals on immunogenicity
Understand immunogenicity from a practical physician`s perspective